386
Views
65
CrossRef citations to date
0
Altmetric
Review

Pharmacological strategies for the prevention of Alzheimer’s disease

&
Pages 1-10 | Published online: 22 Dec 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Walter J Lukiw. (2008) Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD). Expert Opinion on Emerging Drugs 13:2, pages 255-271.
Read now
Vincenzo Tumiatti, Maria Laura Bolognesi, Anna Minarini, Michela Rosini, Andrea Milelli, Riccardo Matera & Carlo Melchiorre. (2008) Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update. Expert Opinion on Therapeutic Patents 18:4, pages 387-401.
Read now
Steven E Prince, Shoshana Woo, P Murali Doraiswamy & Jeffrey R Petrella. (2008) Functional MRI in the early diagnosis of Alzheimer’s disease: is it time to refocus?. Expert Review of Neurotherapeutics 8:2, pages 169-175.
Read now
Roberto Scatena, Giuseppe E Martorana, Patrizia Bottoni, Giorgia Botta, Paola Pastore & Bruno Giardina. (2007) An update on pharmacological approaches to neurodegenerative diseases. Expert Opinion on Investigational Drugs 16:1, pages 59-72.
Read now
Emma RLC Vardy, Ishrut Hussain & Nigel M Hooper. (2006) Emerging therapeutics for Alzheimer’s disease. Expert Review of Neurotherapeutics 6:5, pages 695-704.
Read now

Articles from other publishers (60)

Hiroyuki Ishiguro & Takashi Kaito. 2022. Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury. Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury 177 186 .
Sabhya RanaMichael D. SunshineJohn J. GreerDavid D. Fuller. (2021) Ampakines Stimulate Diaphragm Activity after Spinal Cord Injury. Journal of Neurotrauma 38:24, pages 3467-3482.
Crossref
L.B. Wollman, K.A. Streeter, A.F. Fusco, E.J. Gonzalez-Rothi, M.S. Sandhu, J.J. Greer & D.D. Fuller. (2020) Ampakines stimulate phrenic motor output after cervical spinal cord injury. Experimental Neurology 334, pages 113465.
Crossref
L. B. Wollman, K. A. Streeter & D. D. Fuller. (2020) Ampakine pretreatment enables a single brief hypoxic episode to evoke phrenic motor facilitation. Journal of Neurophysiology 123:3, pages 993-1003.
Crossref
Jack Rogers, Ning Xia, Angela Wong, Rachit Bakshi & Catherine Cahill. (2019) Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity. International Journal of Molecular Sciences 20:4, pages 994.
Crossref
Huarong Xu, Zhenru Wang, Lin Zhu, Zhenyu Sui, Wenchuan Bi, Ran Liu, Kaishun Bi & Qing Li. (2018) Targeted Neurotransmitters Profiling Identifies Metabolic Signatures in Rat Brain by LC-MS/MS: Application in Insomnia, Depression and Alzheimer’s Disease. Molecules 23:9, pages 2375.
Crossref
Prasenjit Mondal, Gaurav Das, Juhee Khan, Krishnangsu Pradhan & Surajit Ghosh. (2017) Crafting of Neuroprotective Octapeptide from Taxol-Binding Pocket of β-Tubulin. ACS Chemical Neuroscience 9:3, pages 615-625.
Crossref
Horia Coman & Bogdan Nemeş. (2017) New Therapeutic Targets in Alzheimer's Disease. International Journal of Gerontology 11:1, pages 2-6.
Crossref
Weiguo Dong, Christine M. Embury, Yaman Lu, Sarah M. Whitmire, Bhagyalaxmi Dyavarshetty, Harris A. Gelbard, Howard E. Gendelman & Tomomi Kiyota. (2016) The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation. Journal of Neuroinflammation 13:1.
Crossref
Bruno Scherrer, S. Andrieu, P.-J. Ousset, G. Berrut, J.-F. Dartigues, B. Dubois, F. Pasquier, F. Piette, P. Robert, J. Touchon, P. Garnier, H. Mathiex-Fortunet & B. Vellas. (2016) Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®. The journal of nutrition, health & aging 19:10, pages 1009-1011.
Crossref
Tomomi Kiyota, Gang Zhang, Christine M Morrison, Megan E Bosch, Robert A Weir, Yaman Lu, Weiguo Dong & Howard E Gendelman. (2015) AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease. Molecular Therapy 23:11, pages 1712-1721.
Crossref
Mathias Hallberg. (2015) Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors. Medicinal Research Reviews 35:3, pages 464-519.
Crossref
Csaba Ádori, Laura Glück, Swapnali Barde, Takashi Yoshitake, Gabor G. Kovacs, Jan Mulder, Zsófia Maglóczky, László Havas, Kata Bölcskei, Nicholas Mitsios, Mathias Uhlén, János Szolcsányi, Jan Kehr, Annica Rönnbäck, Thue Schwartz, Jens F. Rehfeld, Tibor Harkany, Miklós Palkovits, Stefan Schulz & Tomas Hökfelt. (2015) Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease. Acta Neuropathologica 129:4, pages 541-563.
Crossref
John W. Wright, Leen H. Kawas & Joseph W. Harding. (2015) The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology 125, pages 26-46.
Crossref
V. Prakash Reddy. 2015. Organofluorine Compounds in Biology and Medicine. Organofluorine Compounds in Biology and Medicine 241 263 .
Seung-Hoon Yang, Jiyoon Kim & YoungSoo Kim. 2015. Aging Mechanisms. Aging Mechanisms 395 415 .
Simon E Ward. 2014. Ion Channel Drug Discovery. Ion Channel Drug Discovery 105 134 .
Jane E. Robinson, Neil P. Evans, Rebecca Dumbell, Anne-Kristin Solbakk, Erik Ropstad & Ira Ronit Hebold Haraldsen. (2014) Effects of inhibition of gonadotropin releasing hormone secretion on the response to novel objects in young male and female sheep. Psychoneuroendocrinology 40, pages 130-139.
Crossref
Qiutian Jia, Yulin Deng & Hong Qing. (2014) Potential Therapeutic Strategies for Alzheimer’s Disease Targeting or Beyond β -Amyloid: Insights from Clinical Trials . BioMed Research International 2014, pages 1-22.
Crossref
Syed Nuruddin, Anette Krogenæs, Ola Brønstad Brynildsrud, Steven Verhaegen, Neil P. Evans, Jane E. Robinson, Ira Ronit Hebold Haraldsen & Erik Ropstad. (2013) Peri-pubertal gonadotropin-releasing hormone agonist treatment affects sex biased gene expression of amygdala in sheep. Psychoneuroendocrinology 38:12, pages 3115-3127.
Crossref
Jun Ren, Floriane Lenal, Michael Yang, Xiuqing Ding & John J. Greer. (2013) Coadministration of the AMPAKINE CX717 with Propofol Reduces Respiratory Depression and Fatal Apneas. Anesthesiology 118:6, pages 1437-1445.
Crossref
Jerzy Leszek, Marta Sochocka & Kazimierz Gąsiorowski. (2012) Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease. Journal of the Neurological Sciences 323:1-2, pages 25-32.
Crossref
Jun Ren, Xiuqing Ding & John J. Greer. (2012) Respiratory depression in rats induced by alcohol and barbiturate and rescue by ampakine CX717. Journal of Applied Physiology 113:7, pages 1004-1011.
Crossref
R. David Grigg, Jared W. Rigoli, Ryan Van Hoveln, Samuel Neale & Jennifer M. Schomaker. (2012) Beyond Benzyl Grignards: Facile Generation of Benzyl Carbanions from Styrenes. Chemistry - A European Journal 18:30, pages 9391-9396.
Crossref
Grazia Tundo, Chiara Ciaccio, Diego Sbardella, Mariaserena Boraso, Barbara Viviani, Massimiliano Coletta & Stefano Marini. (2012) Somatostatin Modulates Insulin-Degrading-Enzyme Metabolism: Implications for the Regulation of Microglia Activity in AD. PLoS ONE 7:4, pages e34376.
Crossref
Hanna Andersson & Mathias Hallberg. (2012) Discovery of Inhibitors of Insulin-Regulated Aminopeptidase as Cognitive Enhancers. International Journal of Hypertension 2012, pages 1-18.
Crossref
Kouichi Yoshinari, Mariko Sakamoto, Laddawan Senggunprai & Yasushi Yamazoe. (2011) Clioquinol is sulfated by human jejunum cytosol and SULT1A3, a human-specific dopamine sulfotransferase. Toxicology Letters 206:2, pages 229-233.
Crossref
Xiaosong Liu & Jian Zhao. (2011) GPCR, a rider of Alzheimer’s disease. Frontiers in Biology 6:4.
Crossref
Hanna Andersson, Heidi Demaegdt, Anders Johnsson, Georges Vauquelin, Gunnar Lindeberg, Mathias Hallberg, Máté Erdélyi, Anders Karlén & Anders Hallberg. (2011) Potent Macrocyclic Inhibitors of Insulin-Regulated Aminopeptidase (IRAP) by Olefin Ring-Closing Metathesis. Journal of Medicinal Chemistry 54:11, pages 3779-3792.
Crossref
Mohammad Haris, Anup Singh, Kejia Cai, Erin McArdle, Matthew Fenty, Christos Davatzikos, John Q. Trojanowski, Elias R. Melhem, Christopher M. Clark & Arijitt Borthakur. (2011) T1ρ MRI in Alzheimer's Disease: Detection of Pathological Changes in Medial Temporal Lobe. Journal of Neuroimaging 21:2, pages e86-e90.
Crossref
Ha-Na Woo, Sang-Ha Baik, Jong-Sung Park, A-Ryeong Gwon, Sunghee Yang, Young-Kwang Yun & Dong-Gyu Jo. (2011) Secretases as therapeutic targets for Alzheimer’s disease. Biochemical and Biophysical Research Communications 404:1, pages 10-15.
Crossref
Wonjin Ji & Ilho Ha. (2010) Drug Development for Alzheimer's Disease: Recent Progress. Experimental Neurobiology 19:3, pages 120-131.
Crossref
Tzong Yuan Wu, Chih-Ping Chen & Tzyy-Rong Jinn. (2010) Alzheimer's Disease: Aging, Insomnia and Epigenetics. Taiwanese Journal of Obstetrics and Gynecology 49:4, pages 468-472.
Crossref
Hanna Andersson, Heidi Demaegdt, Georges Vauquelin, Gunnar Lindeberg, Anders Karlén, Mathias Hallberg, Máté Erdélyi & Anders Hallberg. (2010) Disulfide Cyclized Tripeptide Analogues of Angiotensin IV as Potent and Selective Inhibitors of Insulin-Regulated Aminopeptidase (IRAP). Journal of Medicinal Chemistry 53:22, pages 8059-8071.
Crossref
John W. Wright & Joseph W. Harding. (2010) The brain RAS and Alzheimer's disease. Experimental Neurology 223:2, pages 326-333.
Crossref
Gang Liu, Ping Men, George Perry & Mark A. Smith. 2010. Free Radicals and Antioxidant Protocols. Free Radicals and Antioxidant Protocols 123 144 .
Hideaki Higashino, Atsuko Niwa, Takao Satou, Yoshio Ohta, Shigeo Hashimoto, Masaki Tabuchi & Kana Ooshima. (2009) Immunohistochemical analysis of brain lesions using S100B and glial fibrillary acidic protein antibodies in arundic acid- (ONO-2506) treated stroke-prone spontaneously hypertensive rats. Journal of Neural Transmission 116:10, pages 1209-1219.
Crossref
Małgorzata Filip & Michael Bader. (2009) Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacological Reports 61:5, pages 761-777.
Crossref
Tzong-Yuan Wu & Chih-Ping Chen. (2009) Dual Action of Memantine in Alzheimer Disease: A Hypothesis. Taiwanese Journal of Obstetrics and Gynecology 48:3, pages 273-277.
Crossref
John J. Greer & Jun Ren. (2009) Ampakine therapy to counter fentanyl-induced respiratory depression. Respiratory Physiology & Neurobiology 168:1-2, pages 153-157.
Crossref
M. CORTES-CANTELI & S. STRICKLAND. (2009) Fibrinogen, a possible key player in Alzheimer’s disease. Journal of Thrombosis and Haemostasis 7, pages 146-150.
Crossref
Catherine M. Cahill, Debomoy K. Lahiri, Xudong Huang & Jack T. Rogers. (2009) Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:7, pages 615-628.
Crossref
Scott Gleim, Aleksandar Stojanovic, Eric Arehart, Daniel Byington & John Hwa. (2009) Conserved Rhodopsin Intradiscal Structural Motifs Mediate Stabilization: Effects of Zinc. Biochemistry 48:8, pages 1793-1800.
Crossref
David Q. Beversdorf & Michael J. Tomasi. (2009) Effect of Luteinizing Hormone-Releasing Hormone Agonists on Behavior in a Patient With Dementia. Journal of Clinical Psychopharmacology 29:1, pages 101-102.
Crossref
Philippe G. Nantermet, Hemaka A. Rajapakse, Mathew G. Stanton, Shaun R. Stauffer, James C. Barrow, Allison R. Gregro, Keith P. Moore, Melissa A. Steinbeiser, John Swestock, Harold G. Selnick, Samuel L. Graham, Georgia B. McGaugheyDennis ColussiMing‐Tain LaiSethu SankaranarayananAdam J. SimonSanjeev MunshiJacquelynn J. CookMarie A. HolahanMaria S. MichenerJoseph P. Vacca. (2009) Evolution of Tertiary Carbinamine BACE‐1 Inhibitors: Aβ Reduction in Rhesus CSF upon Oral Dosing. ChemMedChem 4:1, pages 37-40.
Crossref
Yif'at Biran, Colin L. Masters, Kevin J. Barnham, Ashley I. Bush & Paul A. Adlard. (2008) Pharmacotherapeutic targets in Alzheimer's disease. Journal of Cellular and Molecular Medicine 13:1, pages 61-86.
Crossref
Melanie-Jayne R. Howes & Peter J. Houghton. 2009. Herbal Drugs: Ethnomedicine to Modern Medicine. Herbal Drugs: Ethnomedicine to Modern Medicine 239 291 .
John W WrightJoseph W Harding. (2008) The angiotensin AT 4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease . Journal of the Renin-Angiotensin-Aldosterone System 9:4, pages 226-237.
Crossref
Andreas A. Argyriou, Panagiotis Polychronopoulos, Gregoris Iconomou, Elisabeth Chroni & Haralabos P. Kalofonos. (2008) A review on oxaliplatin-induced peripheral nerve damage. Cancer Treatment Reviews 34:4, pages 368-377.
Crossref
Mohammad A. Kamal, Xianqin Qu, Qian-sheng Yu, David Tweedie, Harold W. Holloway, Yazhou Li, Yi Tan & Nigel H. Greig. (2008) Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis. Journal of Neural Transmission 115:6, pages 889-898.
Crossref
Rosario Pignatello, Valentina Pantò, Stefano Salmaso, Sara Bersani, Venerando Pistarà, Vladimir Kepe, Jorge R. Barrio & Giovanni Puglisi. (2007) Flurbiprofen Derivatives in Alzheimer’s Disease: Synthesis, Pharmacokinetic and Biological Assessment of Lipoamino Acid Prodrugs. Bioconjugate Chemistry 19:1, pages 349-357.
Crossref
Gulay Filiz, Aphrodite Caragounis, Laura Bica, Tai Du, Colin L. Masters, Peter J. Crouch & Anthony R. White. (2008) Clioquinol inhibits peroxide-mediated toxicity through up-regulation of phosphoinositol-3-kinase and inhibition of p53 activity. The International Journal of Biochemistry & Cell Biology 40:5, pages 1030-1042.
Crossref
Leonel E. Rojo, Jorge A. Fernández, Andrea A. Maccioni, José M. Jimenez & Ricardo B. Maccioni. (2008) Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease. Archives of Medical Research 39:1, pages 1-16.
Crossref
Davide Cervia & Paola Bagnoli. (2007) An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. Pharmacology & Therapeutics 116:2, pages 322-341.
Crossref
Livia C. HoolBen Corry. (2007) Redox Control of Calcium Channels: From Mechanisms to Therapeutic Opportunities. Antioxidants & Redox Signaling 9:4, pages 409-435.
Crossref
Joseph Martin Alisky. (2007) The coming problem of HIV-associated Alzheimer’s disease. Medical Hypotheses 69:5, pages 1140-1143.
Crossref
. 2007. Medication Management in Care of Older People. Medication Management in Care of Older People 153 170 .
W.J. LukiwN.G. Bazan. (2006) Survival signalling in Alzheimer's disease. Biochemical Society Transactions 34:6, pages 1277-1282.
Crossref
Erik D. RobersonLennart Mucke. (2006) 100 Years and Counting: Prospects for Defeating Alzheimer's Disease. Science 314:5800, pages 781-784.
Crossref
. (2006) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 21:7, pages 703-710.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.